Microsoft used Build 2026 to launch seven in-house MAI models, new Cobalt 200 silicon and the Majorana 2 quantum chip, a ...
Although medications with glucagon-like peptide-1 (GLP-1) receptor agonist activity have transformed the management of obesity and shown substantial cardiometabolic benefits, unmet needs remain.
In an MRI substudy, the researchers found that survodutide improved body composition and liver fat content, with a 34% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results